Literature DB >> 15942869

Screening of yeasts as probiotic based on capacities to colonize the gastrointestinal tract and to protect against enteropathogen challenge in mice.

Flariano S Martins1, Regina M D Nardi, Rosa M E Arantes, Carlos A Rosa, Maria J Neves, Jacques R Nicoli.   

Abstract

Probiotics are defined as viable microorganisms that exhibit a beneficial effect on the host's health when they are ingested. Two important criteria are used for selection of probiotic microorganisms: they must be able to survive in the gastrointestinal environment and to present at least one beneficial function (colonization resistance, immunomodulation or nutritional contribution). Generally, in vitro assays demonstrating these properties were used to select probiotics but it is unclear if the data can be extrapolated to in vivo conditions. In the present work, twelve Saccharomyces cerevisiae strains isolated from different environments (insect association, tropical fruit, cheese and "aguardente" production) and pre-selected for in vitro resistance to simulated gastrointestinal conditions were inoculated in germ-free mice to evaluate their real capacity to colonize the mammal digestive tract. Using these data, one of the yeasts (S. cerevisiae 905) was selected and tested in gnotobiotic (GN) and conventional (CV) mice for its capacity to protect against oral challenge with two enteropathogenic bacteria (Salmonella Typhimurium and Clostridium difficile). The yeast reached populational levels potentially functional in the gastrointestinal portions where the enteropathogens tested act. No antagonism against either pathogenic bacterium by the yeast was observed in the digestive tract of GN mice but, after challenge with S. Typhimurium, mortality was lower and liver tissue was better preserved in CV animals treated with the yeast when compared with a control group (p<0.05). Histopathological results of intestines showed that the yeast also presented a good protective effect against oral challenge with C. difficile in GN mice (p<0.05). In conclusion, among the 12 S. cerevisiae tested, strain 905 showed the best characteristics to be used as a probiotic as demonstrated by survival capacity in the gastrointestinal tract and protective effect of animals during experimental infections.

Entities:  

Mesh:

Year:  2005        PMID: 15942869     DOI: 10.2323/jgam.51.83

Source DB:  PubMed          Journal:  J Gen Appl Microbiol        ISSN: 0022-1260            Impact factor:   1.452


  20 in total

Review 1.  Systematic review and meta-analysis of Saccharomyces boulardii in adult patients.

Authors:  Lynne V McFarland
Journal:  World J Gastroenterol       Date:  2010-05-14       Impact factor: 5.742

2.  In vitro investigation of Debaryomyces hansenii strains for potential probiotic properties.

Authors:  Honeylet Sabas Ochangco; Amparo Gamero; Ida M Smith; Jeffrey E Christensen; Lene Jespersen; Nils Arneborg
Journal:  World J Microbiol Biotechnol       Date:  2016-07-18       Impact factor: 3.312

3.  Probiotic yeasts: anti-inflammatory potential of various non-pathogenic strains in experimental colitis in mice.

Authors:  Benoît Foligné; Joëlle Dewulf; Pascal Vandekerckove; Georges Pignède; Bruno Pot
Journal:  World J Gastroenterol       Date:  2010-05-07       Impact factor: 5.742

4.  Novel insights in genetic transformation of the probiotic yeast Saccharomyces boulardii.

Authors:  Bruno Douradinha; Viviane C B Reis; Matthew B Rogers; Fernando A G Torres; Jared D Evans; Ernesto T A Marques
Journal:  Bioengineered       Date:  2013-09-05       Impact factor: 3.269

Review 5.  Probiotics and Psychobiotics: the Role of Microbial Neurochemicals.

Authors:  Alexander V Oleskin; Boris A Shenderov
Journal:  Probiotics Antimicrob Proteins       Date:  2019-12       Impact factor: 4.609

6.  Yeasts from kefir grains: isolation, identification, and probiotic characterization.

Authors:  Gabriela Diosma; David E Romanin; María F Rey-Burusco; Alejandra Londero; Graciela L Garrote
Journal:  World J Microbiol Biotechnol       Date:  2013-07-04       Impact factor: 3.312

Review 7.  Do you have a probiotic in your future?

Authors:  Maria G Dominguez-Bello; Martin J Blaser
Journal:  Microbes Infect       Date:  2008-08-13       Impact factor: 2.700

8.  Preventive effects of different probiotic formulations on travelers' diarrhea model in wistar rats : preventive effects of probiotics on TD.

Authors:  Jean-François Bisson; Sophie Hidalgo; Pascale Rozan; Michaël Messaoudi
Journal:  Dig Dis Sci       Date:  2009-05-13       Impact factor: 3.199

9.  Probiotics for the treatment of Clostridium difficile associated disease.

Authors:  Leo R Fitzpatrick
Journal:  World J Gastrointest Pathophysiol       Date:  2013-08-15

10.  In Vitro and In Vivo Evaluation of the Probiotic Potential of Antarctic Yeasts.

Authors:  Joana O P A Coutinho; Taynara S Peixoto; Graciéle C A de Menezes; Camila R Carvalho; Mayara B Ogaki; Eldon C Q Gomes; Carlos A Rosa; Luiz H Rosa; Rosa M E Arantes; Jacques R Nicoli; Fabiana C P Tiago; Flaviano S Martins
Journal:  Probiotics Antimicrob Proteins       Date:  2021-03-23       Impact factor: 4.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.